AI assistant
NANOCO GROUP PLC — Director's Dealing 2018
Oct 16, 2018
4931_dirs_2018-10-16_90dabf82-4057-4c05-938b-33da2527b608.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2005E
Nanoco Group PLC
16 October 2018
16 October 2018
NANOCO GROUP PLC
("Nanoco", the "Group", or the "Company")
Director Share Purchase
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, received notification today that Brian Tenner, Chief Operating Officer and Chief Financial Officer, purchased 158,543 ordinary shares of £0.10 each ("Ordinary Shares") in the Company on 16 October 2018 at a price of 32.0p per Ordinary Share.
Following this transaction, Brian has a beneficial interest in 158,543 Ordinary Shares, all of which are directly held. This interest represents approximately 0.055 per cent. of the total voting rights in the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Brian Tenner |
| 2 | Reason for the notification Purchase of Ordinary Shares | |
| a) | Position/status | Chief Operating Officer & Chief Financial Officer |
| b) | Initial notification/Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Nanoco Group plc |
| b) | LEI | England & Wales Company Number: 05067291 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares |
| Identification code | NANO ISIN GB00B01JLR99 |
|
| b) | Nature of the transaction | Acquisition of Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) 32.0p Volume(s) 158,543 |
| d) | Aggregated information | Price(s) 32.0p Volume(s) 158,543 |
| e) | Date of transaction | 16 October 2018 |
| f) | Place of transaction | London Stock Exchange |
For further information, please contact:
| Nanoco | Tel: +44 (0) 161 603 7900 |
| Michael Edelman, Chief Executive Officer | |
| Brian Tenner, Chief Operating and Financial Officer | |
| Caroline Watson, Investor Relations Manager | Tel: + 44 (0) 7799 897357 |
| [email protected] | |
| Peel Hunt | Tel: +44 (0) 20 7418 8900 |
| Adrian Trimmings | |
| George Sellar | |
| Guy Pengelley | |
| MHP Communications | Tel: +44 (0) 20 3128 8570 |
| Reg Hoare / Giles Robinson / Pete Lambie | |
| [email protected] | |
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.
Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFKADDKBDDDKD